Delivery Order SPE2DB24D2003-SPE2DB25FXDN5

Award Date 11/19/24
Potential Completion Date 11/20/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,054.92, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 20, 2024. The contract was awarded on November 19, 2024 and does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,360.38, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 26, 2025. The contract was awarded on March 25, 2025, and there was no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,713.52 Firm Fixed Price Delivery Order contract is for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" pharmaceutical products. The contract has an ultimate completion date of April 22, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price structure, valued at $1,962.08, for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.6ML medical products. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This is a federal delivery order contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,509.40, is for the provision of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,987.05, is a delivery order contract for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,694.49, is a delivery order for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical supplies. It is a firm fixed-price contract with a completion date of January 24, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,619.04, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of February 13, 2025 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,112.35, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,914.02, is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical supplies. This is a firm fixed-price delivery order contract with an ultimate completion date of February 25, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXDN5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,355.52, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:30 PM